Arbutus Biopharma (ABUS) Ownership - Who Owns Arbutus Biopharma?

1,274 Followers

Arbutus Biopharma (ABUS) Ownership Overview

0.05% Insiders

9.89% Mutual Funds

28.15% Other Institutional Investors

10.56% ETFs

51.35% Public Companies and

Individual Investors

The ownership structure of Arbutus Biopharma (ABUS) stock is a mix of institutional, retail, and individual investors. Approximately 48.60% of the company’s stock is owned by Institutional Investors, 0.05% is owned by Insiders, and 51.35% is owned by Public Companies and Individual Investors.

The ownership structure of Arbutus Biopharma (ABUS) stock is a mix of institutional, retail, and individual investors. Approximately 38.04% of the company’s stock is owned by Institutional Investors, 0.05% is owned by Insiders, and 10.56% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Western Standard Llc	xxxxxxxxxxxxx	$2347142
Mar 31, 2024	Woodline Partners Lp	xxxxxxxxxxxxx	$9045774
Mar 31, 2024	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$495554

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	7,958,865	Institution	4.03%	35,337,361
	7,527,837	Institution	3.81%	33,423,596
	6,460,580	Institution	3.27%	28,684,975
	3,935,631	Institution	1.99%	17,474,202
	3,418,946	Institution	1.73%	15,180,120
	2,695,269	Institution	1.36%	11,966,994
Michael Rockefeller	2,010,172	Institution	1.02%	8,925,164
	1,601,957	Institution	0.81%	7,112,689
	1,559,360	Institution	0.79%	6,923,558
	903,143	Institution	0.46%	4,009,955

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
6,460,580	Institution	3.27%	28,684,975
3,935,631	Institution	1.99%	17,474,202
2,695,269	Institution	1.36%	11,966,994
1,601,957	Institution	0.81%	7,112,689
1,559,360	Institution	0.79%	6,923,558
903,143	Institution	0.46%	4,009,955
703,917	Institution	0.36%	3,125,391
484,841	Institution	0.25%	2,152,694
432,384	Institution	0.22%	1,919,785
105,053	Institution	0.05%	466,435

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	4,811,847	Institution	2.44%	21,653,312
iShares Russell 2000 ETF	3,540,569	Institution	1.79%	15,259,852
SPDR S&P BIOTECH ETF	2,445,434	Institution	1.24%	10,735,455
Vanguard Extended Market ETF	1,731,789	Institution	0.88%	7,793,051
iShares Russell 2000 Growth ETF	1,181,638	Institution	0.60%	5,092,860
iShares Biotechnology ETF	1,110,142	Institution	0.56%	4,784,712
Schwab U.S. Small-Cap ETF	745,957	Institution	0.38%	3,274,751
Vanguard Russell 2000 ETF	745,105	Institution	0.38%	3,352,973
SPDR S&P Kensho New Economies Composite ETF	630,961	Institution	0.32%	2,769,919
Vanguard Health Care ETF	430,645	Institution	0.22%	1,937,903

FAQ

Who Owns Arbutus Biopharma Corporation (ABUS)?

According to the latest TipRanks data, approximately 28.15% of the company's stock is held by institutional investors, 0.05% is held by insiders, and 51.35% is held by retail investors.

What percentage of Arbutus Biopharma Corporation (ABUS) stock is held by institutional investors?

According to the latest TipRanks data, approximately 28.15% of Arbutus Biopharma Corporation (ABUS) stock is held by institutional investors.

What percentage of Arbutus Biopharma Corporation (ABUS) stock is held by retail investors?

According to the latest TipRanks data, approximately 51.35% of Arbutus Biopharma Corporation (ABUS) stock is held by retail investors.

Who owns the most shares of Arbutus Biopharma Corporation (ABUS)?

Vanguard owns the most shares of Arbutus Biopharma Corporation (ABUS).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.